{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:19:07Z","timestamp":1783448347262,"version":"3.55.0"},"reference-count":29,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":108,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["210755\/Z\/18\/Z, 219496\/Z\/19\/Z"],"award-info":[{"award-number":["210755\/Z\/18\/Z, 219496\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIHR Cambridge Biomedical Research Centre"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Restoration of euthyroidism in patients with thyrotoxicosis prior to thyroidectomy is recommended to decrease perioperative morbidity and thyroid storm risk. This is challenging when conventional anti-thyroid medication is contraindicated or ineffective. Iopanoic acid (IOPA), an iodinated contrast medium formerly used as an oral cholecystographic agent, may facilitate treatment of thyrotoxicosis, but limited manufacture precludes its use in the UK. We investigated the effectiveness and safety of IOPA for optimizing thyroid status in treatment-resistant thyrotoxicosis prior to thyroidectomy at a referral centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>With prior permission of our Drug and Therapeutics Committee, we sourced laboratory-grade (&amp;gt;98% pure) IOPA and administered this orally to control ongoing, severe thyrotoxicosis prior to thyroidectomy in 12 patients with inadequate response to standard therapies. Underlying aetiologies included Graves\u2019 disease, amiodarone-induced thyrotoxicosis, toxic multinodular goitre and resistance to thyroid hormone beta. Medical case notes were reviewed retrospectively to analyse clinical and biochemical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All patients exhibited a decline and normalization\/near-normalization of free T3 (FT3) levels (mean 55% decrease, SEM 4.5%), with minimal changes in FT4 levels. Eleven patients proceeded to uneventful thyroidectomy, and IOPA was well tolerated with no directly attributable side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IOPA is a safe and effective agent for controlling biochemical thyrotoxicosis in preparation for thyroidectomy, including disease refractory to conventional medication. Highly pure, laboratory-grade iopanoic acid that is approved for human use is now available in the UK; consideration should be given to more widespread use for emergency treatment of life-threatening hyperthyroidism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0350","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:03:48Z","timestamp":1772031828000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":0,"title":["Iopanoic acid rapidly restores euthyroidism in refractory thyrotoxicosis pre-thyroidectomy: a retrospective study"],"prefix":"10.1530","volume":"15","author":[{"given":"Christine","family":"Newman","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Saqlain","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isra Ahmed","family":"Mohammed","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bell","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Lyons","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Jani","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Fish","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Wood","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Tapa","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Halsall","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Oddy","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-8854","authenticated-orcid":true,"given":"Krishna","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0847-2884","authenticated-orcid":true,"given":"Nadia","family":"Schoenmakers","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7318-7166","authenticated-orcid":true,"given":"Carla","family":"Moran","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"2026070714005303800_bib1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: a review","volume":"330","author":"Lee","year":"2023","journal-title":"JAMA"},{"key":"2026070714005303800_bib2","first-page":"340","article-title":"Amiodarone and the thyroid: a 2012 update","volume":"35","author":"Bogazzi","year":"2012","journal-title":"J Endocrinol Investig"},{"key":"2026070714005303800_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1067\/msy.2002.128561","article-title":"Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy","volume":"132","author":"Bogazzi","year":"2002","journal-title":"Surgery"},{"key":"2026070714005303800_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF03343984","article-title":"Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy","volume":"25","author":"Bogazzi","year":"2002","journal-title":"J Endocrinol Investig"},{"key":"2026070714005303800_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-8587(23)00155-9","article-title":"Cardiovascular morbidity and mortality in patients in Wales, UK with resistance to thyroid hormone \u03b2 (RTH\u03b2): a linked-record cohort study","volume":"11","author":"Okosieme","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070714005303800_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/js.2017-00204","article-title":"Homozygous resistance to thyroid hormone beta: can combined antithyroid drug and triiodothyroacetic acetic acid treatment prevent cardiac failure?","volume":"1","author":"Moran","year":"2017","journal-title":"J Endocr Soc"},{"key":"2026070714005303800_bib7","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1210\/jcem.86.5.7484","article-title":"Clinical review 129: oral cholecystographic agents and the thyroid","volume":"86","author":"Braga","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714005303800_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12020-017-1461-8","article-title":"Lugol\u2019s solution and other iodide preparations: perspectives and research directions in Graves\u2019 disease","volume":"58","author":"Calissendorff","year":"2017","journal-title":"Endocrine"},{"key":"2026070714005303800_bib9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40618-014-0136-z","article-title":"An update on the medical treatment of Graves\u2019 hyperthyroidism","volume":"37","author":"Marin\u00f2","year":"2014","journal-title":"J Endocrinol Investig"},{"key":"2026070714005303800_bib10","first-page":"3191","article-title":"Treatment of hyperthyroidism with a combination of methimazole and cholestyramine","volume":"81","author":"Mercado","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714005303800_bib11","doi-asserted-by":"crossref","first-page":"5794054","DOI":"10.1155\/2018\/5794054","article-title":"Nonthionamide drugs for the treatment of hyperthyroidism: from present to future","volume":"2018","author":"Suwansaksri","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2026070714005303800_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000112975","article-title":"The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients","volume":"17","author":"Akin","year":"2008","journal-title":"Med Princ Pract"},{"key":"2026070714005303800_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jca.21927","article-title":"Therapeutic plasmapheresis for the treatment of thyrotoxicosis: a retrospective multi-center study","volume":"36","author":"Builes-Monta\u00f1o","year":"2021","journal-title":"J Clin Apher"},{"key":"2026070714005303800_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.jp.7211046","article-title":"Iopanoic acid in the management of neonatal Graves\u2019 disease","volume":"24","author":"Earles","year":"2004","journal-title":"J Perinatol"},{"key":"2026070714005303800_bib15","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1210\/jc.2003-031981","article-title":"Rapid preoperative preparation for severe hyperthyroid Graves\u2019 disease","volume":"89","author":"Panzer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714005303800_bib16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.2002-021874","article-title":"Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study","volume":"88","author":"Bogazzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714005303800_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-3476(98)70332-4","article-title":"Successful treatment of massive acute thyroid hormone poisoning with iopanoic acid","volume":"132","author":"Brown","year":"1998","journal-title":"J Pediatr"},{"key":"2026070714005303800_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/JCP.0000000000000418","article-title":"Iopanoic acid to treat acute psychiatric crisis associated with thyrotoxicosis: three case reports and review of the literature","volume":"35","author":"Way","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"2026070714005303800_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1210\/jc.2003-031629","article-title":"Chopra IJ treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid","volume":"89","author":"Dhillon","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714005303800_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2265.1991.tb03562.x","article-title":"Rapid preoperative preparation in hyperthyroidism","volume":"35","author":"Baeza","year":"1991","journal-title":"Clin Endocrinol"},{"key":"2026070714005303800_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM196907102810207","article-title":"Brief recordings. Acute renal failure after the administration of iopanoic acid as a cholecystographic agent","volume":"281","author":"Canales","year":"1969","journal-title":"N Engl J Med"},{"key":"2026070714005303800_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jama.1964.03070100065019","article-title":"Athrombocytosis following oral cholecystography","volume":"189","author":"Bishopric","year":"1964","journal-title":"JAMA"},{"key":"2026070714005303800_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/105072501750302868","article-title":"The use of oral radiographic contrast agents in the management of hyperthyroidism","volume":"11","author":"Fontanilla","year":"2001","journal-title":"Thyroid"},{"key":"2026070714005303800_bib24","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1172\/JCI109755","article-title":"Inhibition of hepatic binding of thyroxine by cholecystographic agents","volume":"65","author":"Felicetta","year":"1980","journal-title":"J Clin Investig"},{"key":"2026070714005303800_bib25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00005537-199708000-00012","article-title":"Sodium ipodate (oragrafin) in the preoperative preparation of Graves\u2019 hyperthyroidism","volume":"107","author":"Tomaski","year":"1997","journal-title":"Laryngoscope"},{"key":"2026070714005303800_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cen.14817","article-title":"Genetic disorders of thyroid development, hormone biosynthesis and signalling","volume":"97","author":"Moran","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026070714005303800_bib27","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1210\/jc.2005-0608","article-title":"Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial","volume":"90","author":"Bal","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714005303800_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1210\/jcem-65-4-679","article-title":"Long term treatment of Graves\u2019 disease with iopanoic acid (telepaque)","volume":"65","author":"Wang","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714005303800_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/BF03347940","article-title":"Therapy of Graves\u2019 disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism","volume":"14","author":"Martino","year":"1991","journal-title":"J Endocrinol Investig"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/15\/2\/ETJ-25-0350.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/15\/2\/ETJ-25-0350.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0350\/503405\/etj-25-0350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0350\/503405\/etj-25-0350.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:01:04Z","timestamp":1783447264000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/2\/ETJ250350\/75636\/Iopanoic-acid-rapidly-restores-euthyroidism-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0350","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"ETJ250350"}}